CAS Number: 1138245-21-2

Stage: Pipeline

Mirogabalin Besylate is a gabapentinoid designed for the treatment of neuropathic pain, including diabetic peripheral neuropathy and postherpetic neuralgia. By binding to the α2δ subunit of voltage-gated calcium channels, Mirogabalin modulates pain signaling with enhanced selectivity and reduced CNS side effects compared to traditional agents. Explore Royal Pharma as your potential partner for Mirogabalin Besylate API.